NASDAQ:IONS Ionis Pharmaceuticals (IONS) News Today $46.28 +3.62 (+8.49%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$43.55▼$46.5450-Day Range$38.50▼$43.6452-Week Range$32.69▼$47.74Volume2.68 million shsAverage Volume1.04 million shsMarket Capitalization$6.63 billionP/E RatioN/ADividend YieldN/APrice Target$47.80 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIonis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Actionmsn.com - September 26 at 3:34 PMIonis late-stage rare disease data fails to impress Bernsteinmsn.com - September 26 at 3:34 PMIonis Climbs On Late-Stage Trial Results For Body Fat Disorderfinance.yahoo.com - September 26 at 3:34 PMIonis Pharma's genetic disorder drug succeeds in late-stage studyreuters.com - September 26 at 10:33 AMIonis Reports Positive Results From Phase 3 Study Of Olezarsen In Familial Chylomicronemia Syndromemarkets.businessinsider.com - September 26 at 10:33 AMIonis Pharma's genetic disorder drug meets main goal in late-stage studyreuters.com - September 26 at 10:33 AMIonis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndromefinance.yahoo.com - September 26 at 10:33 AMUPDATE 2-Ionis' metabolic disorder drug lowers high levels of a type of fat in studyfinance.yahoo.com - September 26 at 10:33 AMArden Trust Co Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - September 24 at 6:58 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Hold" by Analystsamericanbankingnews.com - September 21 at 2:26 AMLeerink Partnrs Comments on Ionis Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:IONS)americanbankingnews.com - September 21 at 1:18 AMQ3 2023 Earnings Forecast for Ionis Pharmaceuticals, Inc. Issued By Leerink Partnrs (NASDAQ:IONS)marketbeat.com - September 20 at 6:07 AMIonis to host investor and analyst day eventfinance.yahoo.com - September 20 at 1:29 AMARK Investment Management LLC Decreases Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - September 15 at 5:17 PMARK Investment Management LLC Decreases Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - September 15 at 5:17 PMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by BVF Inc. ILmarketbeat.com - September 12 at 4:39 AMWhy Is Ionis Pharmaceuticals (IONS) Up 1.4% Since Last Earnings Report?finance.yahoo.com - September 8 at 4:14 PMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Bought by Rhumbline Advisersmarketbeat.com - September 7 at 4:29 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Hold" by Analystsmarketbeat.com - August 27 at 2:18 AMExodusPoint Capital Management LP Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - August 25 at 11:16 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Russell Investments Group Ltd.marketbeat.com - August 24 at 4:32 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Stock Position Decreased by Federated Hermes Inc.marketbeat.com - August 22 at 4:38 AMTower Research Capital LLC TRC Boosts Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - August 21 at 5:37 AM15,571 Shares in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Acquired by Mirae Asset Global Investments Co. Ltd.marketbeat.com - August 20 at 4:10 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.marketbeat.com - August 18 at 6:38 AMQ3 2023 EPS Estimates for Ionis Pharmaceuticals, Inc. Lifted by Analyst (NASDAQ:IONS)marketbeat.com - August 14 at 2:17 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Stake Lowered by Sicart Associates LLCmarketbeat.com - August 11 at 9:23 PMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 11 at 5:42 PMBarclays Remains a Hold on Ionis Pharmaceuticals (IONS)markets.businessinsider.com - August 10 at 4:43 PMIonis Pharmaceuticals (IONS) Reports Q2 Results: What Key Metrics Have to Say (Revised)msn.com - August 10 at 11:32 AMQ2 2023 Ionis Pharmaceuticals Inc Earnings Callfinance.yahoo.com - August 10 at 11:32 AMIonis reports second quarter 2023 financial resultsfinance.yahoo.com - August 9 at 7:28 AMNovartis and Ionis in pact for new cardiovascular therapyseekingalpha.com - August 3 at 1:29 PMIonis enters collaboration to advance next generation program targeting Lp(a) for cardiovascular diseasefinance.yahoo.com - August 3 at 8:28 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Amalgamated Bankmarketbeat.com - August 3 at 4:39 AMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - August 2 at 2:26 AMThis little-known pharma stock can rally 50%, Citi sayscnbc.com - July 31 at 1:34 PMIonis completes enrollment in landmark Phase 3 CARDIO-TTRansform study in patients with TTR-mediated amyloid cardiomyopathyfinance.yahoo.com - July 31 at 8:33 AMPrivium Fund Management B.V. Increases Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - July 28 at 8:46 PMIonis expands eplontersen agreement with AstraZeneca to include exclusive rights in Latin Americafinance.yahoo.com - July 28 at 10:24 AMIonis to hold second quarter 2023 financial results webcastfinance.yahoo.com - July 26 at 11:30 PMIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.marketbeat.com - July 23 at 4:33 AMThe Fight Against Alzheimer’s Goes Beyond Plaque. Tangles Are a Target, Too.barrons.com - July 19 at 8:04 AMBridgeBio unveils positive results from rare heart disease drug trial, shares jumpfinance.yahoo.com - July 17 at 1:19 PMPeregrine Capital Management LLC Raises Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - July 14 at 5:51 AMDekaBank Deutsche Girozentrale Has $5.72 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - July 13 at 5:02 AMBard Financial Services Inc. Reduces Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)marketbeat.com - July 12 at 8:23 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and RegenXBio (RGNX)markets.businessinsider.com - July 12 at 1:46 AMIonis (IONS) Posts Encouraging Data From Amyloidosis Drug Studyfinance.yahoo.com - July 11 at 3:46 PMEplontersen continued to show improvement in ATTRv-PN through 85 weeksfinance.yahoo.com - July 10 at 7:16 AM Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address IONS Media Mentions By Week IONS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IONS News Sentiment▼0.700.53▲Average Medical News Sentiment IONS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IONS Articles This Week▼174▲IONS Articles Average Week Get Ionis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IONS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALKS News Today IMGN News Today FOLD News Today MDGL News Today UTHR News Today DVAX News Today ALNY News Today ELAN News Today RETA News Today KRTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:IONS) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.